HBIO

Harvard Bioscience, Inc.

4.36 USD
-0.05 (-1.13%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Harvard Bioscience, Inc. stock is down -5.42% since 30 days ago. The next earnings date is Mar 7, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 54.17% of the previous 23 February’s closed higher than January.

About Harvard Bioscience, Inc.

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as instruments and accessories for tissue and organ-based lab research.